Archive for Февраль 8th, 2007
Side-Effects May Be Similar to Rimonabant ( Acomplia/Zimulti)
Diet drug taranabant, a CB-1 receptor inverse agonist which many hoped would have a better side-effect profile than Sanofi’s CB-1 receptor antagonist rimonabant Rimonabant ( Acomplia//Zimulti), may have similar problems, according to an analyst for investment bank Leerink Swann.
Analyst Aileen Salares, in a research report based on an abstract [...]
Waiting for More Acomplia Trial Results
When two year results of the RIO-North America (Rimonabant In Obesity) trial were presented at the American Heart Association (AHA) scientific meeting in New Orleans in November, researchers said additional results from studies underway could be expected by the end of the year.
But seven weeks have passed with no [...]
